MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
17 09 2019
Historique:
received: 21 02 2018
revised: 16 05 2019
accepted: 20 06 2019
pubmed: 14 8 2019
medline: 18 12 2019
entrez: 13 8 2019
Statut: ppublish

Résumé

Natural killer (NK) cells are cytotoxic type 1 innate lymphoid cells (ILCs) that defend against viruses and mediate anti-tumor responses, yet mechanisms controlling their development and function remain incompletely understood. We hypothesized that the abundantly expressed microRNA-142 (miR-142) is a critical regulator of type 1 ILC biology. Interleukin-15 (IL-15) signaling induced miR-142 expression, whereas global and ILC-specific miR-142-deficient mice exhibited a cell-intrinsic loss of NK cells. Death of NK cells resulted from diminished IL-15 receptor signaling within miR-142-deficient mice, likely via reduced suppressor of cytokine signaling-1 (Socs1) regulation by miR-142-5p. ILCs persisting in Mir142

Identifiants

pubmed: 31402259
pii: S1074-7613(19)30286-9
doi: 10.1016/j.immuni.2019.06.016
pmc: PMC6750984
mid: NIHMS1537077
pii:
doi:

Substances chimiques

MicroRNAs 0
Mirn142 microRNA, mouse 0
Receptors, Interleukin-15 0
Suppressor of Cytokine Signaling Proteins 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-490.e6

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK103039
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA173878
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125615
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA171963
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA205239
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007200
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127752
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA101937
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025884
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007088
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA143379
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL090775
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA200253
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI078994
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA197369
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009547
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI102924
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI129110
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI095542
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Immunity. 2016 May 17;44(5):1127-39
pubmed: 27156386
Nat Commun. 2015 Oct 05;6:8523
pubmed: 26436920
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
Immunity. 2014 Sep 18;41(3):354-365
pubmed: 25238093
J Immunol. 2013 Jun 15;190(12):6269-76
pubmed: 23656738
Cell. 2010 Sep 17;142(6):847-56
pubmed: 20850008
Cell. 2019 Jan 10;176(1-2):348-360.e12
pubmed: 30595449
Immunity. 2014 Oct 16;41(4):646-56
pubmed: 25367576
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Blood. 2013 Feb 7;121(6):1016-27
pubmed: 23212522
Sci Signal. 2016 Feb 16;9(415):ra19
pubmed: 26884601
Lab Invest. 2010 Apr;90(4):543-55
pubmed: 20142803
Haematologica. 2017 Dec;102(12):e476-e480
pubmed: 28912177
J Immunol. 2011 Nov 15;187(10):5162-9
pubmed: 21967894
J Clin Oncol. 2008 Dec 1;26(34):5610-7
pubmed: 18981465
J Exp Med. 2011 Dec 19;208(13):2717-31
pubmed: 22124110
Science. 2015 Nov 20;350(6263):981-5
pubmed: 26472762
J Clin Invest. 2015 Jul 1;125(7):2825-40
pubmed: 26098216
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18324-9
pubmed: 22021440
J Immunol. 2014 May 15;192(10):4487-91
pubmed: 24740507
J Biol Chem. 2001 Jul 27;276(30):27757-63
pubmed: 11333270
Immunity. 2015 Jul 21;43(1):52-64
pubmed: 26163372
J Immunol. 2015 Sep 15;195(6):2806-17
pubmed: 26268657
J Immunol. 2012 Apr 1;188(7):3019-30
pubmed: 22379033
Immunity. 2007 Jun;26(6):798-811
pubmed: 17540585
Blood. 2015 Jun 11;125(24):3720-30
pubmed: 25931583
Nat Rev Immunol. 2008 Apr;8(4):259-68
pubmed: 18340344
Annu Rev Immunol. 2006;24:657-79
pubmed: 16551262
J Exp Med. 2014 Mar 10;211(3):563-77
pubmed: 24516120
J Histochem Cytochem. 1998 Mar;46(3):371-7
pubmed: 9487119
Nat Immunol. 2016 Jul;17(7):816-24
pubmed: 27213690
J Immunol. 2013 Dec 15;191(12):5904-13
pubmed: 24227772
J Biol Chem. 1986 Mar 25;261(9):4337-45
pubmed: 3456347
Elife. 2014 May 23;3:e01964
pubmed: 24859754
Cell Rep. 2016 Aug 2;16(5):1339-1351
pubmed: 27452457
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Elife. 2014 Jan 01;3:e01659
pubmed: 24714492
J Exp Med. 2000 Mar 6;191(5):771-80
pubmed: 10704459
FASEB J. 2014 Jun;28(6):2696-704
pubmed: 24558198
Blood. 2002 Nov 15;100(10):3633-8
pubmed: 12393617
Clin Immunol. 2017 Apr;177:60-69
pubmed: 26948928
J Exp Med. 2017 Dec 4;214(12):3627-3643
pubmed: 29122948
Front Immunol. 2013 Dec 12;4:450
pubmed: 24376448
Nat Immunol. 2017 Sep;18(9):995-1003
pubmed: 28759002
Int Immunol. 2008 Dec;20(12):1483-7
pubmed: 18824503
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6967-72
pubmed: 23572582
Nat Immunol. 2017 Sep;18(9):1004-1015
pubmed: 28759001
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E700-9
pubmed: 25646418
Annu Rev Immunol. 2004;22:405-29
pubmed: 15032583
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6161-5
pubmed: 7541142
Genome Res. 2010 Nov;20(11):1590-604
pubmed: 20935160
Blood. 2011 Nov 17;118(20):5439-47
pubmed: 21931117
Biochem Biophys Res Commun. 2014 Jan 17;443(3):980-6
pubmed: 24361879

Auteurs

Melissa M Berrien-Elliott (MM)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Yaping Sun (Y)

Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.

Carly Neal (C)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Aaron Ireland (A)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Maria C Trissal (MC)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Ryan P Sullivan (RP)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Julia A Wagner (JA)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Jeffrey W Leong (JW)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Pamela Wong (P)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Annelise Y Mah-Som (AY)

Department of Pediatrics, Division of Rheumatology, Washington University School of Medicine, Saint Louis, MO, USA.

Terrence N Wong (TN)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Timothy Schappe (T)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Catherine R Keppel (CR)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Victor S Cortez (VS)

Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA.

Efstathios G Stamatiades (EG)

Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Ming O Li (MO)

Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Marco Colonna (M)

Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA.

Daniel C Link (DC)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.

Anthony R French (AR)

Department of Pediatrics, Division of Rheumatology, Washington University School of Medicine, Saint Louis, MO, USA.

Megan A Cooper (MA)

Department of Pediatrics, Division of Rheumatology, Washington University School of Medicine, Saint Louis, MO, USA.

Wei-Le Wang (WL)

Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Mark P Boldin (MP)

Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Pavan Reddy (P)

Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.

Todd A Fehniger (TA)

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA. Electronic address: tfehnige@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH